With respect to neurodegeneration biomarkers, plasma NfL has showed promise as a biomarker for early AD neurodegeneration (Bangen et al., 2021; Gerards et al., 2022; Giacomucci et al., 2022). The gene discussed is NEFL; the disease is Alzheimer disease.